Sorbitan Monocaprylate Synergy in Cosmetic Formulations

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Cosmetic, dermatological, and pharmaceutical formulations face challenges with the use of antimicrobial alcohols, as they can reduce viscosity and cause phase separation, and their maximum permissible concentrations may not adequately protect against microbial attacks while being dermatologically and toxicologically harmless.

Innovation Solution

The use of sorbitan monocaprylate, which is dermatologically and toxicologically harmless, synergistically enhances the antimicrobial effect of antimicrobial alcohols, maintaining formulation viscosity and allowing higher concentrations without phase separation, thereby reducing the required amount of antimicrobial alcohols needed for effective preservation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antimicrobial alcohols are used in higher concentrations to protect against microbial attack, then the antimicrobial effect is improved, but the viscosity of the formulation is reduced and phase separations occur

Engineering Contradiction:
Improveantimicrobial protectionVSAvoidformulation viscosity and phase stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces sorbitan monocaprylate as an intermediary substance that mediates between the antimicrobial alcohol and the formulation system. This emulsifying agent allows higher alcohol concentrations to be used without causing viscosity reduction or phase separation, as it stabilizes the formulation structure while permitting the antimicrobial component to function at effective levels.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If the concentration of antimicrobial alcohols is increased beyond maximum permissible limits, then the antimicrobial effect is enhanced, but dermatological and toxicological safety is compromised

Engineering Contradiction:
Improveantimicrobial protectionVSAvoiddermatological and toxicological harm
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the formulation parameters by introducing sorbitan monocaprylate, which enables the system to use alcohol concentrations that are optimally effective for antimicrobial protection without exceeding the maximum permissible limits for safety. The emulsifying agent alters the physical-chemical parameters of the formulation, allowing sustained alcohol presence at safe yet effective concentrations.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If maximum permissible concentrations of alcohols are used to ensure safety, then dermatological and toxicological safety is maintained, but adequate protection against microbial attack is not achieved

Engineering Contradiction:
Improvedermatological and toxicological safetyVSAvoidantimicrobial protection
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

Sorbitan monocaprylate acts as a synergistic intermediary that enhances the antimicrobial effectiveness of the alcohol at safe concentrations. The emulsifying agent modifies the microenvironment or interaction dynamics, allowing the alcohol to exhibit improved antimicrobial activity at concentrations that remain within safety limits, thus achieving both protection and safety simultaneously.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Sorbitan monocaprylate supports the antimicrobial effect of alcohols, allowing for reduced alcohol concentrations in formulations, maintaining viscosity, and preventing phase separation, thus effectively preserving cosmetic, dermatological, and pharmaceutical products while ensuring safety and efficacy.

Implementation Method 1

sorbitan monocaprylate synergistically supports the antimicrobial effect of antimicrobial alcohols

Methodology Applied
Scientific EffectSynergistic effect:

Implementation Method 2

sorbitan monocaprylate does not reduce the viscosity of a cosmetic, dermatological or pharmaceutical formulation, but on the contrary even has slightly thickening properties

Methodology Applied
Scientific EffectViscosity stabilization:

Implementation Method 3

significantly higher amounts of sorbitan monocaprylate can be used without reducing the viscosity of the cosmetic, dermatological or pharmaceutical formulation or promoting phase separation

Methodology Applied
Scientific EffectPhase stabilization:

Implementation Method 4

sorbitan monocaprylate, which is already known and used in cosmetics as a surfactant and emulsifying agent

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 5

sorbitan monocaprylate, which is already known and used in cosmetics as a surfactant and emulsifying agent

Methodology Applied
Scientific EffectEmulsification: Emulsion

Data Source

PatentEP2432317B1Composition containing sorbitan monocaprylate and alcohol
Publication Date: 2013.07.17 CLARIANT FIANCE (BVI) LTD

AI summary

The invention relates to liquid compositions which contain a) from 5 to 95% by weight of sorbitan monocaprylate and b) from 5 to 95% by weight of one or more alcohols of formula (1) R−OH (1), wherein R is a group consisting of carbon, hydrogen and optionally oxygen atoms with 5 to 12, preferably 6 to 11, carbon atoms, and the carbon atoms can be interlinked in a linear, branched and/or cyclic fashion via saturated, unsaturated and/or aromatic carbon-carbon bonds and the groups can also contain ether units and hydrogen atoms and/or hydroxyl groups can be bound to the individual carbon atoms. The liquid compositions are suitable for the production of cosmetic, dermatological or pharmaceutical products.